GMAB vs. EQH
GMAB (Genmab A/S) and EQH (Equitable Holdings, Inc.) are both stocks. GMAB operates in Biotechnology (Healthcare), while EQH operates in Insurance - Diversified (Financial Services). Over the past 5 years, GMAB returned -10.53%/yr vs 9.89%/yr for EQH. At a 0.20 correlation, their price movements are largely independent.
Performance
GMAB vs. EQH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GMAB achieves a -18.57% return, which is significantly lower than EQH's -6.30% return.
GMAB
- 1D
- -0.63%
- 1M
- -5.50%
- YTD
- -18.57%
- 6M
- -19.90%
- 1Y
- 9.90%
- 3Y*
- -13.28%
- 5Y*
- -10.53%
- 10Y*
- 4.28%
EQH
- 1D
- 0.94%
- 1M
- 4.14%
- YTD
- -6.30%
- 6M
- -7.48%
- 1Y
- -12.50%
- 3Y*
- 20.47%
- 5Y*
- 9.89%
- 10Y*
- —
GMAB vs. EQH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
GMAB Genmab A/S | -18.57% | 47.58% | -34.45% | -24.87% | 7.13% | -2.71% | 82.09% | 35.54% | -18.76% |
EQH Equitable Holdings, Inc. | -6.30% | 3.17% | 45.04% | 19.63% | -10.17% | 31.00% | 6.52% | 53.13% | -14.75% |
Correlation
The correlation between GMAB and EQH is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since May 10, 2018 | 0.20 |
Fundamentals
GMAB:
$4.10
EQH:
-$3.67
GMAB:
1.81
EQH:
0.87
GMAB:
$8.84B
EQH:
$11.32B
GMAB:
$8.27B
EQH:
$6.96B
GMAB:
$3.81B
EQH:
-$759.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GMAB vs. EQH — Risk / Return Rank
GMAB
EQH
GMAB vs. EQH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Genmab A/S (GMAB) and Equitable Holdings, Inc. (EQH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GMAB | EQH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.72 | ||
| Sortino ratioReturn per unit of downside risk | +1.05 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 0.94 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.27 | -0.42 | +0.68 |
| Martin ratioReturn relative to average drawdown | 0.58 | -0.82 | +1.40 |
Loading charts...
Drawdowns
GMAB vs. EQH - Drawdown Comparison
The maximum GMAB drawdown since its inception was -84.20%, which is greater than EQH's maximum drawdown of -61.33%. Use the drawdown chart below to compare losses from any high point for GMAB and EQH.
Loading charts...
Drawdown Indicators
| GMAB | EQH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.20% | -61.33% | -22.87% |
Max Drawdown (1Y)Largest decline over 1 year | -32.51% | -35.85% | +3.34% |
Max Drawdown (3Y)Largest decline over 3 years | -57.44% | -35.85% | -21.59% |
Max Drawdown (5Y)Largest decline over 5 years | -63.10% | -35.85% | -27.25% |
Max Drawdown (10Y)Largest decline over 10 years | -63.10% | — | — |
Current DrawdownCurrent decline from peak | -48.52% | -19.51% | -29.01% |
Average DrawdownAverage peak-to-trough decline | -31.09% | -12.12% | -18.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.86% | 18.23% | -3.37% |
Volatility
GMAB vs. EQH - Volatility Comparison
Genmab A/S (GMAB) has a higher volatility of 12.15% compared to Equitable Holdings, Inc. (EQH) at 9.41%. This indicates that GMAB's price experiences larger fluctuations and is considered to be riskier than EQH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GMAB | EQH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.15% | 9.41% | +2.74% |
Volatility (6M)Calculated over the trailing 6-month period | 25.57% | 25.38% | +0.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.45% | 31.86% | +2.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.47% | 33.05% | +0.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.19% | 38.75% | -3.56% |
Dividends
GMAB vs. EQH - Dividend Comparison
GMAB has not paid dividends to shareholders, while EQH's dividend yield for the trailing twelve months is around 2.52%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
EQH Equitable Holdings, Inc. | 2.52% | 2.20% | 1.99% | 2.58% | 2.72% | 2.17% | 2.58% | 2.34% | 1.56% |
GMAB Genmab A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
GMAB vs. EQH - Financials Comparison
This section allows you to compare key financial metrics between Genmab A/S and Equitable Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GMAB vs. EQH - Profitability Comparison
GMAB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a gross profit of 834.08M and revenue of 899.32M. Therefore, the gross margin over that period was 92.8%.
EQH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Equitable Holdings, Inc. reported a gross profit of 3.61B and revenue of 4.23B. Therefore, the gross margin over that period was 85.2%.
GMAB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported an operating income of 225.83M and revenue of 899.32M, resulting in an operating margin of 25.1%.
EQH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Equitable Holdings, Inc. reported an operating income of 0.00 and revenue of 4.23B, resulting in an operating margin of 0.0%.
GMAB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a net income of 53.20M and revenue of 899.32M, resulting in a net margin of 5.9%.
EQH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Equitable Holdings, Inc. reported a net income of 621.00M and revenue of 4.23B, resulting in a net margin of 14.7%.
Frequently Asked Questions
GMAB and EQH have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GMAB has higher volatility (12.15%) compared to EQH (9.41%). In terms of maximum drawdown, GMAB dropped -84.20% vs EQH's -61.33%.
GMAB currently has the higher Sharpe Ratio (0.25 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GMAB and EQH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer